HILL NANCY LOUISE 4
4 · Adaptive Biotechnologies Corp · Filed Dec 16, 2020
Insider Transaction Report
Form 4
HILL NANCY LOUISE
Sr Vice President, Operations
Transactions
- Exercise/Conversion
Common Stock
2020-12-14$0.84/sh+40,000$33,600→ 50,000 total - Sale
Common Stock
2020-12-14$59.00/sh−40,000$2,360,000→ 10,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-14−40,000→ 59,000 totalExercise: $0.84Exp: 2023-11-03→ Common Stock (40,000 underlying)
Holdings
- 500(indirect: By Ryan Hill (son))
Common Stock
- 400(indirect: By Brandon Hill (son))
Common Stock
- 300(indirect: By Connor Hill (son))
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- [F3]The option is fully vested and exercisable.